JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nastuk, W. L.
Right arrow Articles by Karis, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nastuk, W. L.
Right arrow Articles by Karis, J. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 144, Issue 2, 236-252, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


THE BLOCKING ACTION OF HEXAFLUORENIUM ON NEUROMUSCULAR TRANSMISSION AND ITS INTERACTION WITH SUCCINYLCHOLINE

W. L. Nastuk 1 and J. H. Karis 1

1 Departments of Physiology and Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, N. Y.

The action of hexafluorenium (HFL) and certain other agents has been studied using the sartorius muscle-sciatic nerve preparation of the frog. Indirect stimulation was used to produce muscle twitches.

In the indirectly stimulated muscle, HFL reduces the twitch tension without preceding twitch potentiation. The twitch depression is reversible; it amounts to 10% with HFL 5 x 10-6 M and it increases to 100% with HFL 30 x 10-6 M. In terms of twitch tension reduction HFL is approximately 15x weaker than d-tubocurarine (dTC).

The fall in twitch tension produced by HFL 20 x 10-6 M is not antagonized by edrophonium (lO to 5O x 1O-6 M).

HFL (10 x 10-6 M) causes marked inhibition of the depolarizing action of acetyicholine on the postjunctional membrane.

HFL (10 x 10-6 M) does not cause any change in the resting potential of the postjunctional membrane. This concentration of HFL produces an increase in the amplitude and rate of repolarization of action potentials neurally initiated at the endplate. The maximum rate of rise of the endplate potential is significantly reduced. No significant change in the critical membrane potential occurs.

In junctions where transmission is blocked by HFL (10 to 30 x 10-6 M) the endplate potential is reduced in amplitude and its time course parallels that seen at junctions blocked with d-tubocurarine.

In preparations treated with HFL (5 x 10-6 M) addition of succinylcholine (SCh) (1.25 to 5 x 10-6 M) and carbamyicholine (11 x 10-6 M) causes a fall in twitch tension with little or no preceding twitch potentiation.

In preparations treated with fluorenyltri-methylammonium (FTMA) (50 x 10-6 M) addition of SCh (5 x 10-6 M) causes a fall in twitch tension which is preceded by a small twitch potentiation.

In preparations treated with dTC (0.36 x 10-6 M) the twitch tension falls about 15%. Addition of SCh (5 x 10-6 M) increases the twitch tension to above control levels.

A fall in twitch tension produced by HFL (5 x 10-6 M) plus SCh (2.5 x 10-6 M) is not antagonized by edrophonium (50 x 10-6 M).

In certain respects the neuromuscular block produced by HFL superficially resembles that produced by dTC but other evidence indicates that these agents do not act in a parallel manner. A scheme is presented in which it is suggested that HFL blocks the mechanism by which the postjunctional membrane becomes depolarized when receptor sites become activated by agents such as ACh. Our results help to explain the clinical observation that HFL augments the neuromuscular block produced by intravenously administered SCh.

Submitted on July 11, 1963
Accepted on December 18, 1963







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.